Although Parkinson's disease is not regarded as a disorder of dopamine metabolism, the identification that GCH1 mutations can lead to Parkinson's disease as well as dopa-responsive dystonia suggests that biochemical depletion of dopamine is likely to have more complicated effects than once thought.45 The gene discussed is GCH1; the disease is Parkinson disease.